project id: TCGA-BRCA; case submitter id: TCGA-B6-A408; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.13; rna integrity number: 7.5; age at index: 55; days to birth: -20102; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1953; age at diagnosis: 20102; ajcc pathologic m: M0; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2072.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8522/3; primary diagnosis: Infiltrating duct and lobular carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1500; initial weight: 50.0; sample id: 8518e829-4248-4f12-b32f-f4019f7ba4e2; sample submitter id: TCGA-B6-A408-01A; portion id: 9561cd17-817a-402c-8f3a-c9326bb6fa37; portion submitter id: TCGA-B6-A408-01A-12; slide id: 1d487fa0-42c1-4c5c-94a4-8d7f48eab98f; slide submitter id: TCGA-B6-A408-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 1.0; percent neutrophil infiltration: 2.0; percent normal cells: 1.0; percent stromal cells: 23.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;